arrow_back Back to App

Support for Genetic Drugs: Extended Protection for Innovation.

This bill aims to extend the protection period for new, advanced genetic drugs, potentially encouraging companies to invest in their development. This could lead to citizens gaining faster access to innovative therapies that may improve quality of life for genetic conditions.
Key points
Extends market protection for genetic drugs from 7 to 11 years.
Defines "advanced drug product" to include drugs using genetically targeted technologies.
May accelerate access to new treatments for individuals with genetic diseases.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_5547
Sponsor: Rep. Nickel, Wiley [D-NC-13]
Process start date: 2023-09-18